How many insider declarations has King-Jones Heidy filed?

King-Jones Heidy has filed 7 public insider declarations with SEC (Form 4).

What is King-Jones Heidy's role?

King-Jones Heidy's reported role is not specified by the regulator across the filings.

Which companies does King-Jones Heidy report trades for?

King-Jones Heidy reports trades for Spyre Therapeutics, Inc..

What is King-Jones Heidy's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2.1M€.

InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

King-Jones Heidy

·SEC (Form 4)

Spyre Therapeutics, Inc.

Cumul. flow

Total declarations

Company

—

▲ Purchases (0 ops.)

€2m

▼ Sales (5 ops.)

Insider track record

Other

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by King-Jones Heidy. Director active across 1 company, notably Spyre Therapeutics, Inc.. In total, 7 filings have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €2.1m. Activity tracked since 1 September 2026. The latest transaction was disclosed on 2 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.